Forgot your password?

Forgot your username?

database > company
Abbott Laboratories
Biotech Specialty Pharma  Advamed Member
100 Abbott Park Road
Abbott Park, IL 60064-3500 USA
phone:(847) 937-6100
fax:
Symbol ABT
Exchange NYSE
Founded 0
Employees 72200
www.abbott.com
Research Sector Biotech Specialty Pharma
Summary Description
global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health.
Management
Miles D. White, Chairman of the Board and Chief Executive Officer; Thomas C. Freyman, Executive Vice President, Finance and Chief Financial Officer; Richard W. Ashley, Executive Vice President, Corporate Development; Olivier Bohuon, Executive Vice President, Pharmaceutical Products; John M. Capek, Ph.D., Executive Vice President, Medical Devices
Ownership
Financials Mkt Cap :70


* numbers in thousands
 

Keywords
pediatric nutrition, pediatrics, anesthetics, drugs

Comment | Printable Version | Modify profile |
Updated: Dec. 01, 2011

Description
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a diversified line of healthcare products.
Products / Services
There are five revenue segments. Pharmaceutical Products sells a line of pharmaceuticals in the United States. Diagnostic Products is a supplier of diagnostic systems and tests for blood banks, hospitals, consumers, commercial laboratories and alternate-care testing sites. Hospital Products is engaged in the United States sales of intravenous and irrigation fluids and related administration equipment, drugs and drug delivery systems, anesthetics, critical care products and other medical specialty products for hospitals and alternate-care sites. Ross Products markets adult and pediatric nutritional products, pediatric pharmaceuticals and consumer products in the United States. International sells Abbott's pharmaceutical, hospital and nutritional products outside the United States. Abbott also has a 50%-owned joint venture, TAP Pharmaceutical Products Inc.
Competitors / Substitutes / Alternatives
Merck & Co Inc (MRK) Roche Holding AG (RHHVF.PK) Sanofi-Aventis (SNY)


2012-02-09-6902